ISSN (printed): 1422-9528. ISSN (electronic): 1424-0556.
Cardiovascular diseases are the most common causes of hospitalization and the predominant contributors to mortality in the Western world. In the wake of this pandemic development, the challenge of curing patients with cardiovascular disorders has attracted some of the brightest minds to the field. Some of these spearheading researchers and clinicians have been instrumental in accelerating novel therapy concepts arising from both basic and clinical science. Consequently, cardiovascular medicine is one of the most rapidly evolving fields. Publishers around the globe are aware of the increasing significance of cardiovascular medicine in the publishing arena. New journals are being launched, many of which attempt to cover whatever potential authors might wish to submit and future subscribers might accept to read. The editors, however, feel that the core of the art of cardiovascular medicine remains at the clinician-scientist who thoroughly studies basic concepts and boldly tests them in clinical settings and who carries the burden of conducting cardiovascular trials, waiting for follow-up results for years, if not decades. These are the people who deserve a new, state-of-the-art cardiovascular journal: HeartDrugô, a journal in which quality of and excellence in clinical science and the courage of taking concepts from bench to bedside receive the highest priority; a journal in which clinicians, industry and academia, government experts and statistical consultants share their views, in order to improve the quality of clinical investigations and to speed up information exchange. HeartDrugô will provide a forum of the highest quality for researchers with a strong drive to achieve clinical results. It is aiming at a rapid review process and an immediate coverage by all major citation machineries.
- Further information
- Category Link